Keyword: Heritage Pharmaceuticals
Only weeks after a former exec in its Sandoz unit pleaded guilty to federal charges, Novartis will pony up $195 million to escape price-fixing claims.
A third generics executive has been charged in a long-running price-fixing probe that has also yielded a settlement with two drugmakers.
Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.
Congressional pharma watchdogs are renewing an earlier request for drug-pricing information, saying three companies might've broken federal law.
Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of contamination concerns.
Heritage Pharmaceuticals is suing a logistics company, a transporter and the Norfolk, Virginia, port for a container of drugs knocked into a river.
Heritage Pharmaceuticals, based in East Brunswick, New Jersey, opened a new manufacturing facility that was built using modular cleanroom walls.
Kroger and other grocery chains are suing Mylan, Teva, Endo and many other companies for an "overarching conspiracy" to artificially inflate prices.
Price-fixing allegations against generics makers just keep piling up, with Mylan, Teva and other players targeted in yet another lawsuit.
Two former Heritage Pharma execs will cooperate with a broad generic pricing probe that's roped in some of the biggest companies in the business.